Over the past 12 months, 0 insiders at Forma Therapeutics Holdings, Inc. filed 0 open-market SEC Form 4 transactions on FMTX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 22 | David N CookSVP, Chief Scientific Officer | SELL | 3.5K | $9.78 | $35K |
| Feb 23, 22 | Patrick F. KellySVP, Chief Medical Officer | SELL | 5.2K | $9.78 | $51K |
| Feb 23, 22 | Frank D. LeePresident and CEO | SELL | 18.0K | $9.78 | $176K |
| Feb 23, 22 | Brian Andrew LesserSVP, Commercial | SELL | 3.8K | $9.78 | $38K |
| Feb 23, 22 | Jeannette PottsSee Remarks | SELL | 4.7K | $9.78 | $46K |
| Feb 23, 22 | Todd ShegogSVP, Chief Financial Officer | SELL | 5.7K | $9.78 | $56K |
| Feb 23, 22 | Mary E. WadlingerSee Remarks | SELL | 4.7K | $9.78 | $46K |
Over the past 12 months, insiders at Forma Therapeutics Holdings, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on FMTX, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at Forma Therapeutics Holdings, Inc. filed open-market SEC Form 4 transactions on FMTX over the last 12 months.
InsiderTape plots every FMTX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Forma Therapeutics Holdings, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →